Search by Drug Name or NDC
NDC 69842-0996-60 CVS Chest Congestion Relief 20; 400 mg/1; mg/1 Details
CVS Chest Congestion Relief 20; 400 mg/1; mg/1
CVS Chest Congestion Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy, Inc.. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 69842-0996-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 69842-0996-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 69842-0996 |
---|---|
Product ID | 69842-996_9aa43dcf-2d6c-4948-bb12-36e656146d90 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | CVS Chest Congestion Relief |
Proprietary Name Suffix | DM |
Non-Proprietary Name | Dextromethorphan Hydrobromide / Guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 20; 400 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | CVS Pharmacy, Inc. |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | 2024-12-31 |
Package
NDC 69842-0996-60 (69842099660)
NDC Package Code | 69842-996-60 |
---|---|
Billing NDC | 69842099660 |
Package | 1 BOTTLE, PLASTIC in 1 CARTON (69842-996-60) / 60 TABLET in 1 BOTTLE, PLASTIC |
Marketing Start Date | 2010-01-11 |
NDC Exclude Flag | N |
Pricing Information | N/A |